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In 2018, of 1.3 million Latinx adults in the United States facing concurrent 
issues with substance use disorders (SUD) and mental health disorders (MHD) 
93% remained untreated for either diagnosis. This is concerning since Substance 
Abuse and Mental Health Services Administration (SAMHSA) data reveals that 
this population is at greater risk for suicidal thoughts, plans, and attempts. They 
also face structural barriers such as employment, housing, legal involvement, 
and insurability that further impede access to treatment.  
This study’s purpose was to examine barriers to accessing treatment for 
Latinx populations confronting co-occurring SUDs and MHDs. This study used a 
qualitative design and data were collected from telephone or zoom interviews 
with five Latinxs who identified themselves as dually diagnosed (DD) within the 
Inland Empire of Southern California. 
This study found that participants reported stigma from the community and 
cultural forces as a major barrier to treatment. The study revealed that 
participants viewed structural factors such as being uninsured, being 
incarcerated, having transportation difficulties, and having work scheduling 
difficulties as barriers to treatment. This study also indicated difficulties in 
diagnosing a DD, which often led to an inability to consider how one diagnosis 
might impact another and ultimately delayed actions to treat a DD.  
It is recommended that social workers ensure understanding of unique DD 
experiences so they can proactively assess for substance use in early 
iv 
adolescence. To address structural barriers, this study recommends universal 
access to medical coverage for all individuals, which ultimately foster advanced 
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As Social Workers enter the professional field they will work with a 
multitude of client populations, each of which having varying and competing 
needs. The population of focus here will be dual-diagnosed (DD) Black and 
Latinx individuals with mental health diagnoses (MHD) and substance use 
disorders (SUD). These comorbidities in addition to racial historical trauma and 
systematic deprivation for minority populations may complicate treatment 
approaches. Clinicians must be aware of the special implications that a DD 
entails for this population. This population’s unique social position warrants an 
exploration into addressing the psycho-social factors that are applicable, with a 
special emphasis on institutional policies such as health care access, legislation, 
and criminal justice. 
According to the Substance Abuse and Mental Health Services 
Administration (SAMHSA) in 2018 there were 1.1 million Black adults who had a 
SUD with a co-occurring mental illness, of which 91% received no treatment for 
either diagnosis (SAMHSA, 2018a). In that same year 1.3 million Latino adults 
had a SUD with a co-occurring mental illness where 93% received no treatment 
for either diagnosis (SAMHSA, 2018b). For both populations SUD with co-
occurring MHD is associated with higher rates of suicidal thoughts, plans and 
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attempts (SAMHSA, 2018a; SAMSA, 2018b). This accounts for about 2.4 million 
people who have specific needs that must be met concurrently. 
Lo and Cheng (2011) discuss the disparities for minority groups within 
healthcare, where often services that are critical for maintaining well-being and 
prevention are not provided, which result in higher rates of mortality from 
substance treatment related conditions through accidents, relapse and violence 
when compared to non-Latinx White populations. The authors explore factors 
that increase rates of mortality such as infrequent access to treatment that may 
arise from cost of care, lack of insurance coverage, discrimination, mistrust 
and/or services that do not provide quality treatment. This study focused on the 
type of treatment that individuals accessed, where specialty treatment was 
defined as consultation with a substance trained professional (operationalized as 
at least several counseling sessions with a psychiatrist, social worker, 
psychologist or similarly trained professional and medication management 
services). Non-specialty treatment was defined as consultation with a health care 
provider not specifically trained in substance or behavioral interventions (Lo & 
Cheng, 2011). 
The Black population was less likely to report accessing specialty 
treatment compared to non-Latinx White populations (Lo & Cheng, 2011). At the 
same time, the Black population and Latinx population were more likely to access 
non-specialty treatment (Lo & Cheng, 2011). The implications of this are 
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important to consider since so few Black and Latino individuals, as noted by 
SAMHSA data, seek treatment to begin with.  
Purpose of Study 
The purpose of this study was geared toward assessing the quality of 
treatment services for dual diagnosed Black and Latinx populations in order to 
understand what treatment areas could be improved upon. To contextualize the 
variability of services, within an analysis of programs meant to treat the DD 
population across the United States, only 18% of addiction focused settings and 
9% of mental health focused settings were able to provide adequate DD specific 
care (McGovern et al., 2014). By studying the efficacy of services, as a means of 
finding methods to improve them, it is possible to cultivate greater participation 
and trust within treatment programs.  
This research was conducted through individual interviews that assessed 
community perceptions and barriers to available services. This was necessary in 
order to calibrate the study measures to the specific Inland Empire region. By 
establishing a clear background of past and/or current treatment access by 
participants, there was a better understanding of the community’s perceptions 
and needs.  
Significance of Study to Social Work 
In order to understand how to rehabilitate and reconstitute communities, 
research into treatment disparities was necessary. Robbins et al. (2011) found 
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that in an analysis of Brief Strategic Family Therapy versus Community-based 
Outpatient programs for SUD, Black adolescents had lower rates of engagement 
and retention compared to peers across treatment type. Alegria et al. (2011) 
notes that disparities in SUD treatment access may be rooted in negative 
attitudes towards help-seeking within Black and Latinx communities compared to 
non-Latinx White communities. The findings of this research sought to establish 
clarity in methods to treat minority communities facing DD comorbidities. Given 
the previous research trend it was important to specifically interview the Inland 
Empire population on its perceptions to treatment programs. 
By engaging in the evaluation phase of the Generalist Intervention Model 
this study has been able to get a sense of the Inland Empire’s ability to address 
and treat DD individuals. By exploring this topic, this research aimed to pioneer a 
revitalized approach to DD treatment outcomes for Black and Latinx populations. 
This research is motivated to create a wider array of treatment approaches that 
will enable greater access to rehabilitation. This research could be beneficial to 
social work students who are in the process of developing their clinical skills. This 
research will also allow for discussion and the development of a necessary 
awareness of the multimodal approaches needed to holistically treat Black and 
Latinx populations. In order to do so, the guiding question was: What are the 
barriers to accessing treatment for Black and Latinx populations confronting 








This chapter consists of an investigation of the challenges to reaching 
adequate treatment and the issues that develop during this process. The 
research is divided into sections where the first portion assessed the psycho-
social implications of legislature and in-practice procedures. This is followed with 
the section on structural implications of dually diagnosed experiences. The final 
subsection discusses the applicability of sociocultural theory and systems theory 
for DD Black and Latinx populations.  
Psycho-social Implications 
Within California after the enactment of Proposition 36 in 2000, a measure 
to redirect individuals with substance related offense away from incarceration 
and into community-based treatments, a comparison between DD individuals and 
their singularly diagnosed substance using counterparts showed an increased 
recidivism for DD individuals who had severe mental health diagnoses (Jaffe et 
al., 2012). These findings also reported an increased rate of incarceration, 
unemployment, unsuccessful substance treatment and rearrests for individuals 
who were DD (Jaffe et al., 2012). Without taking Prop 36 into account, the 
likelihood of individuals who were DD to initiate and engage in treatment was 
less likely for men with schizophrenia and individuals who were actively drug 
dependent with recent arrests (Brown et al., 2011). Although positive connection 
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and support from family may have aided in initiation and engagement of 
substance treatment; severe symptoms, chaotic living circumstances, poor self-
care, poor life functioning, poor symptom management and legal obligations 
impacted the ability to seek and engage in treatment (Brown et al., 2011). There 
is a need to consider the structural forces (legal obligations, lack of housing, 
homelessness, transportation issues and time/schedule requirements) that drive 
this population away from service initiation and engagement (Brown et al., 2011). 
The psycho-social impact that these inter-dynamic issues illustrate is a highly 
complex lived experience that necessitates the ability to actively manage 
individuals’ symptomology and behavioral approaches concurrently. Otherwise, 
the amount of strain that this interplay has on individuals may very well 
exacerbate already present issues; thereby impacting their ability to enroll in 
treatment.   
Wu and Hser (2011) researched Prop 36 treatment providers and found 
that during the initial year only 53% of the workforce was certified as substance 
use counselors, additionally of that group only 56% of the certified counselors 
(meaning roughly one-fourth of total staff) had a master’s degree or higher 
education. The authors note that as funding increased to enrich workforce staff, 
the amount of staff that was not certified or that held higher education degrees 
remained similar. These types of facilities were the kind that where available to 
individuals seeking to initiate services to manage their symptoms. With this 
having been the case, the question of whether or not ethical practices were used 
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arises. This must be explored since the previously mentioned psycho-social 
burdens can lead to an increased difficulty for retention or disengagement.  
In a review of 11 guidelines for treating co-occurring substances and 
mental illnesses, Perron et al. (2010) found that all guidelines were intended to 
be used by medical professionals while of those, only 8 were meant to be used 
by behavioral health professionals. Of these 11 guidelines only 2 provided in-
depth treatment protocols while the others remained vague and open for 
interpretations by facilities (Perron et al., 2010). Perron et al. (2010) specifically 
drew attention to the differences between American Psychiatric Association 
(APA) guidelines for schizophrenia with dual substance use and those for bipolar 
disorder, which lacked protocols for co-occurring substance treatment even 
though there are higher prevalences for co-occurring substance use for bipolar 
disorders. When facilities come across these types of guidelines, which lack 
necessary specificity to adequately treat DD populations, there is a danger of 
malfeasance in their application.  
  Although there is research supporting the need for dual diagnoses 
treatment integration, the field is still in need of perfecting techniques to reach 
larger populations. The role of social workers is to expand the ground leveled 
practice to incorporate a more cohesive treatment for DD populations. Further 
efforts to do this will likely entail efforts on shifting ideologies surrounding 
substance use policies within legislature and the larger social world. Going 
further, structural components such as housing, employment, transportation, and 
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similar needs will have to be coordinated as part of a holistic dual diagnoses 
treatment, especially for systems impacted individuals.  
Structural Implications 
Veterans with a DD of Post-Traumatic Stress Disorder (PTSD) and SUD 
tend to self-medication through illicit substances to lessen the symptoms of 
PTSD, which exacerbated their daily functioning by debilitating psycho-social 
skills (Owens et al., 2014). Owens et al. (2014) found that veteran groups with 
DD (PTSD and SUD) and those with only PTSD and no SUD had higher rates of 
depression and avoidant attachments to their peers when compared to groups 
diagnosed with only SUD and no PTSD. This suggests that the MHD within DD 
groups may be an indication of higher risk to psycho-social functioning issues, 
when compared to groups that expressed a singular SUD diagnosis without 
MHDs. It is important to explore the interactional effect of multiple diagnoses to 
better clinicians’ understandings of treatment approaches, as not doing so would 
result in deteriorated psycho-social functioning, specifically in the case of 
accessing treatment. In the case of DD alcohol use with anxiety, use of Cognitive 
Behavioral Therapy (CBT) to simultaneously treat comorbidities was shown to 
reduce alcohol dependencies while having no observable effect on other 
substances when comparing to individuals receiving services for a singular 
diagnoses of SUD or anxiety (Wolitzky-Taylor et al., 2018). This finding suggests 
that addressing the MHD comorbidity while simultaneously addressing the SUD 
through psychotherapeutic approaches could have greater impacts in treatment 
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methods overall, since the accompanying MHD comorbidity may be driving SUD 
behaviors (Wolitzky-Taylor et. al, 2018). 
Given the nature of clinical work and the urgency needed to diagnose, 
clinicians may elect to focus on SUDs singularly as they may be more apparent. 
This could cause negative consequences for clients since there are nuances 
within DD MHD and SUD that go beyond the needs of SUD alone. For instance, 
Minkoff (2019) discusses the propensity of clinicians to diagnose individuals in 
substance related crises with substance-induced disorders instead of properly 
investigating client psychiatric histories for information that could lead to more 
appropriate care/treatment. Minkoff (2019) asserts the possibility of gathering a 
more complete background through analyzing mental states within periods of 
sobriety in addition to collateral information so that clinicians may accurately 
assess the contexts that triggered the substance related crisis. Temporarily 
stabilizing SUDs while leaving obscure MHDs untreated, may lead to cyclical 
patterns of relapse and continued SUD, which may only worsen over time.  
Mericle et al. (2012) notes that individuals with DD are more likely to have 
poorer health, face housing and employment difficulties, and have histories of 
suicide attempts. The consequences of improperly diagnosing DD may result in 
the loss of social capital within communities. Given the prevalence of substance 
use and its effects on marginal social spaces, SUD is a major issue that robs 
communities of potential through the loss of unrealized potential from individual 
members. This means that in order to holistically address DD within this 
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structural setting there must be a re-integrative approach to treatment. Some 
aspects of this community re-integration approach are present in an analysis of 
SUD on homeless individuals (where homelessness is a structural comorbidity 
that affects psychological functioning). Carver et al. (2020) found that the manner 
in which treatment interventions were provided made the biggest impact in 
increasing the homeless’ likelihood of substance abstinence. Homeless 
individuals were able to receive transitional services that ensured their likelihood 
to retain homes with basic training in home skills and substance avoidance within 
a hospitable and empathetic environment (Carver et. al, 2020). 
In a multiracial and ethnic study that assessed Individuals’ co-occurring 
disorders of SUD and MHD, Mericle et al. (2012) found that despite White 
populations having a higher occurrence of DD SUD and MHD; Black, Latino and 
Asian populations with DD SUD and MHD were more likely to be unemployed. 
The authors also noted that Black populations were underrepresented in access 
to psychiatric hospitalization, noting potential differences in access to care or in 
help seeking behaviors as potential explanations for this. Compared to peers 
who only had either SUD or MHD, those experiencing DD tend to be more 
vulnerable to psychosocial impairments across race and ethnicity (Mericle et al., 
2012). Additionally, most respondents with DD reported that they experienced 
symptoms of MHD prior to developing symptoms of SUD, which points toward 
the need for SUD prevention as an important treatment objective when 
individuals are first treated for early onset MHDs (Mericle et al., 2012).  
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In order to understand the DD population’s barriers to treatment more 
comprehensively, an intersectional analysis is necessary to dissect the structural 
implications of accessing treatment. For example, looking more closely at the 
disproportionality of unemployment for minorities with DD should shed light on 
structural inequalities, specifically tied to racial and ethnic backgrounds.  
Theories Guiding Conceptualization: Sociocultural and Systems Theory 
Alegria et al. (2011) proposes a sociocultural framework of health service 
disparities through six levels of analysis on 1) federal and economic health care 
policies and regulations, 2) operations of the health care system and provider 
organization, 3) provider level factors, 4) social and economic forces on 
environment, 5) the community system, and 6) client leveled factors in order to 
understand the creation and maintenance of health service disparities. This 
adaptation of Vygotsky’s Sociocultural theory describes a similar functionality of 
cultural influence on an individuals’ functioning within a system, where through 
engagement within varying levels of structural components ranging from the 
individual to the community to the economic and political levels an individual 
learns how to access health care.  
Additionally, Systems Theory could be beneficial to provide a schema of 
interrelating mechanisms that would illustrate health care functioning. A special 
emphasis on the overarching system, subsystems, their relationships and 
ascribed roles, inputs and outputs, as well as feedback and interface analysis 
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could help to determine where the system is lacking engagement (Zastrow & 
Kirst-Ashman, (2016, 2019).  
Summary 
There is a need to further study treatment disparities within DD Black and 
Latino populations due to lacking research in treatment outcomes. The psycho-
social barriers in combination with structural barriers further obfuscate the issue. 
A detailed examination of various sublevels within the sociocultural framework 
serves as a foundation to further explore and understand the system in which 
these populations exist. By establishing a consolidated understanding of these 
phenomena and reflecting upon it through community input, the next steps in 







This research explored the perspectives of individuals in seeking and 
accessing treatment for DD SUD and MHD. The methods of this analysis are 
described in this section. Further discussion on the study design, sampling, data 
collection and instruments, procedures, protection of human subjects, and data 
analysis follows.    
Study Design 
The purpose of this study was to explore the factors that affect individual 
participation in seeking and accessing treatment for DD SUDs and MHDs 
disorders for the Black and Latino populations within the Inland Empire of 
Southern California. This was done through the use of qualitative interviews with 
participants. Qualitative interviews were chosen in order to allow individuals the 
chance to explore the factors that have impacted their access while also 
assessing the feelings towards seeking and accessing treatment. Through 
collecting the direct experiences of individuals who are missing from the data, the 
data collection aided in establishing a necessary foundation of information for the 
issue of low treatment access and participation for this population. Through 
detailing the direct experiences of individuals, the discourse became client 
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centered. This allowed for emphasis on the needs and opinions of individuals as 
the guiding framework for future work in addressing treatment gaps.  
A limitation to this research was COVID-19’s effects on information 
gathering. Individuals may have been less inclined to participate in interviews 
with researchers via technological methods due to the lack of human interaction 
and discomfort surrounding privacy. Individuals may have been opposed to 
online or telephonic interviews with strangers in general. Additionally, locating 
participants who fit study criteria proved difficult since individuals may not have 
been formally diagnosed. Individuals may not have been aware of applicable 
diagnoses that would have made them applicable for study. Participants may 
have felt stigmatized and preferred not to participate in research. There may also 
have been cultural factors, historical trauma, doubt, or suspicion that inhibited 
participation within the research process. In addition, there will be a limitation on 
how generalizable the data is to the national population since it was focused on a 
small participant pool and specific regional area.  
A strength to this research was the ability to contextualize the Inland 
Empire’s experiences within the issue of treatment access. With this specific 
knowledge it may be possible to better develop methods of attracting Black and 
Latinx individuals towards seeking and participating in treatment. In addition to 
these benefits, the participants’ insights may be applied to the development of 
treatment approaches and interventions. Further research can be developed to 




The research sample was gathered through purposive and snowball 
sampling and consisted of 5 participants who slightly varied in gender identity 
and identified as Latinx and were formally or informally diagnosed in having DD 
SUDs and MHDs. No individuals that identified as Black participated. Participants 
were solicited to contact the researcher if they were interested in participating 
through flyers (Appendix D) indicating the type of research to be conducted with 
a brief description of qualifications and time needed to participate.  
Data Collection and Instruments 
IRB approval was granted to conduct qualitative interviews that were 
audio-recorded from telephonic or Zoom videoconferencing technologies. 
Interviews began with informed consent (Appendix C) and an explanation of the 
purpose for the research. The researcher gathered demographic data through a 
demographic survey (Appendix A) focused on racial/ethnic identification, gender 
identification, age, educational level, geographical background, medical 
insurance coverage, annual income, and applicable diagnoses. 
Each interview followed the interview guide (Appendix B) that was 
available in English and Spanish. The guide was composed of open-ended 
questions that focused on eliciting participants’ thoughts and feelings of their 
personal experiences. The areas of discussion were individual feelings in 
navigating community spaces as a DD individual, family and cultural/community 
perceptions of DD experiences and treatment options, and individual or familial 
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support in seeking treatment or other types of assistance. The researcher also 
probed further if certain answers were unclear or would benefit from further 
explanation.  
Procedures 
The researcher created a flyer advertising the project with a $10 gift card 
incentive to participate, a brief description of the type of study and the 
demographic of interest with contact information of the researcher. These flyers 
were distributed by Project Rebound at California State University, San 
Bernardino that had accepted partnership after IRB approval. The researcher 
coordinated around the schedules of participants in order to allow greater access 
to interview times. Participants were able to decide what method they preferred 
to use, telephone or video call, when signing up. Interviews were done in a 1:1 
format. The researcher e-mailed all confidentiality and informed consent 
documents to participants in advance of interviews. If email was not a good 
method of receiving this documentation, the researcher acquired verbal consent 
to participate in the study after reviewing informed consent documents with 
participants.  
During interviews, the researcher reviewed the informed consent 
document and discussed confidentiality to ensure participants were aware of the 
information and protocols. The researcher reminded participants that they had 
the right to disclose the amount of information they felt comfortable disclosing 
and that they had the freedom to resign from the study at any point in time. The 
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researcher took additional notes as participants spoke in order to create a visual 
flow chart of ideas and develop content connections. If participants became 
upset or distressed during the interview, the researcher paused to assess their 
wellbeing and de-escalate with breathing exercises or de-briefing. Once 
participants were stable the researcher would ask if they wished to continue and 
remind them that they were not obligated to continue. Once interviews were 
completed the researcher took the time to assess the participant’s emotional 
state and give debriefing statements (Appendix E). The researcher also provided 
local resources in case the participant was interested in seeking support or future 
services. The researcher thanked the participant for their time and participation.  
Protection of Human Subjects 
Participants were given pseudonyms upon signing up for the study. After 
which the researcher only referred to participants by their pseudonyms in all 
forms of communication. Actual names were recorded with pseudonyms in a 
physical document that was locked within a case folder. Digital audio recordings 
were kept in a password protected flash drive that was locked with physical logs. 
Recordings were transcribed with researcher created code names for further 
identity protection. Once information was processed it was discussed in broad 
categories/charts in order to make re-identification of participants difficult. These 




Demographics variables were analyzed using descriptive statistics. The 
interview data was first transcribed chronologically as presented in interviews. 
Then the data was analyzed by major and minor themes through a content 
analysis process. Individual code names were be created for this transcription 
process in order to further remove identifying features. The transcripts included 
non-verbal sounds and body language/movements if any were relevant to 
dialogue.  
Summary 
The best approach to understanding perspectives of individuals in seeking 
and accessing treatment for dual diagnoses SUDs and MHDs was through 
qualitative interviews. Information provided by participants aided to delineate the 









This chapter will cover participant demographics and applicable personal 
backgrounds. A discussion of major themes involving first use/onset, individual 
conceptualization on MHD intersecting with SUD, experiences in treatment 
access and use, motivations and barriers toward treatment, DD management 
techniques, personal and cultural opinions toward treatment, as well as exploring 
support mechanisms.  
Findings 
Demographics 
A total of 5 participants who volunteered for this study met criteria for 
research participation. This sample was compromised of 4 self-identified Males 
(80%) and 1 self-identified Female (20%). All participants identified as Latinx or a 
similar subgroup (such as Chicano, Hispanic, Mexican). No participants identified 
as Black or African American.  
The median age of participants was 40 years old, with 25 years being the 
youngest and 44 years old being the oldest. Two participants ranged from 25-35 
years old. Three participants ranged from 36-45 years old. Participant 
educational levels were broad with two participants having completed high school 
or a high school equivalent, one participant currently in college leveled 
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coursework, and two participants with bachelor’s leveled degrees. All participants 
lived within the Inland Empire for the last 10 years at time of study. Two 
participants had medical insurance through Medi-Cal, two participants had 
medical insurance coverage through their employment, and one participant had 
no medical insurance. Average annual income was $32,000, ranging from 
$12,000 to $55,000 annually.  
All participants had a varied history of substance use with accompanying 
mental health diagnosis, or characterization of sufficient symptomologies to 
warrant identification by individuals. Substance use was classified as problematic 
to functioning in order for it to be relevant to study. Substance use varied from 
alcohol to stimulants as well as opioids with 80% of individuals (4 participants) 
reporting often using more than one type of substance. Two of the participants 
experienced neurodevelopmental diagnoses, specifically ADHD and Specified 
Learning Disorder. One participant experienced anxiety disorder. The two 
remaining participants experienced Schizophrenia spectrum disorders, 
specifically Schizoaffective bipolar type and Schizoaffective depressive type. 
Initial Onset of Mental Health Disorders and Substance Use Disorders 
The average age of substance use was 13.6 years with sixty percent (3) 
individuals reporting alcohol as initial substance. On average the participants 
reported experiencing their first MHD symptoms at 16.2 years old. Participants 
with neurodevelopmental and anxiety disorders experienced early onset of MHD 
and SUD when compared to schizophrenic spectrum disorder. 
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Neurodevelopmental and anxiety prone individuals experienced MHD at younger 
ages from ranging from 8 to 13 years old. This group reported initial substance 
use ranging from 10 to 13 years old. Schizophrenic spectrum participants 
experienced MHD later in life, with MHD presenting at age 19 and 28. Of this 
group, participants began using substances at 22 and 10, respectively. Eighty 
percent (4 participants) reported first having a MHD symptom before initiating 
substance use.   
Historical Conceptualization of Mental Health Disorders and Substance Use 
Disorders 
Respondents reported a common theme of environmental stressors within 
a range of social settings as heavily influencing their substance initiation. For the 
three participants (60%) with neurodevelopmental and anxiety disorders, 
environmental stressors were predominately school based where academic 
performance and social interactions, respectively, caused dysphoria. Two 
participants (40%) with schizophrenic spectrum disorders experienced family-
based stressors that initiated substance use. Participant 1 explained their first 
substance use 
Started out smoking pot, thought, it was fun. There was, you know, uh, 
from pot it turned to… sniffing paint, it’s just, the experience for me, its 
just, I guess it made me, uh, like my… I b- I basically, it just made me feel 
numb to where I just… Like, how do you say… suppress my feelings while 
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I was still inside? (Participant 1, personal communication, January 14, 
2021).  
Additionally, two (40%) participants of each group experienced grief from the loss 
of a significant family member which caused more serious substance use 
frequency as compared to previous self-reported use.  
When participants were asked if they felt there were any connection 
between MHD and SUD, three participants (60%) in the neurodevelopmental and 
anxiety group reported that dysphoric emotions from MHD led into substance 
use. For example, Participant 3 reported  
When all of my other classmates were acing their tests and stuff that, I 
guess it just kinda made me want to just go hang out with the people, you 
know, that there were also messing up and those people, those people 
were doing like drugs and alcohol (Participant 3, personal communication, 
February 18, 2021).  
Two participants (40%) with schizophrenic spectrum disorders reported that MHD 
symptoms had always been present but that substances made them worse. 
When asked about a possible connection between MHD and SUD Participant 4 
stated that the MHD was already present but that substances exacerbated it with, 
“I really do feel like it got worse, but it didn't, it wasn't determinate- It didn't 




Treatment of Mental Health Disorders and Substance Use Disorders  
In terms of having received treatment, 40% (2 participants) received no 
treatment while the remaining 60% (3 participants) received a type of DD 
treatment through in-patient services and/or outpatient services. Two participants 
(40%) that utilized outpatient DD services who also utilized peer-support groups, 
prior to COVID-19’s emergence. Participant 4 expressed how crucial this support 
was by stating 
Also especially group therapy where others are experiencing the same 
problem that you have, that way you can relate to others, and you feel like 
you're not the only one, you know, like there's other people going through 
this too (Participant 4, personal communication, February 9, 2021).  
At time of study all participants reported maintenance of symptom management 
with continuation of treatment, if enrolled in treatment. Those that accessed 
treatment reported overall pleasant feelings towards care and providers. One 
respondent, however, had an instance of negligent care characterized by rapid 
and unprecipitated changes to treatment that resulted in serious relapse prior to 
being on a stabilized treatment. Participant 1 reported,  
I was with one doctor and we had got the medications down, I thought that 
I was doing really good. And then, but he retired. then the other doctor 
came in and she, from the minute I met her, she was just like, ‘Oh, I know 
this. I've been doing this for this many years. And you're on too much of 
this and you're on too much of that.’ And she basically like took 
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medications away, started prescribing new ones. (Participant 1, personal 
communication, January 14, 2021). 
Barriers and Facilitators to Treatment 
Respondents reported barriers to treatment as: structural limitations, such 
as not having insurance and concern over out-of-pocket costs; a need to work in 
order to provide for family; feelings of being able to control drug dependencies 
through a desire to combat SUD independently; and cultural stigma in accessing 
treatment. Participant 2 summarized these conflicting issues with, “providing for 
my family, um, having to be, um, placed in a residential setting, um, being away 
from my family, um, you know, the job restraints” (Participant 2, personal 
communication, January 26, 2021). Participant 5 echoes these sentiments in 
explaining their hesitancy for treatment as an uninsured person as “mostly an 
economical issue than the desire to seek help.” (Participant 5, personal 
communication, February 9, 2021). Additionally, participant 5 reported their 
family’s distrust “when it comes to medication for treating mental health and 
mental illness.” continuing with, “I think everything to the point of psychiatry is 
okay.” (Participant 5, personal communication, February 9, 2021). 
Participants stated motivations for seeking treatment to be: fear of losing 
family and family support system, having family support in trying to access care 
as well as concern for wellbeing, and a desire for self-understanding of 
symptoms and their triggers. Participant 3 stated a motivation to change was 
rooted in fear of losing their family 
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Just losing my family. Like, uh, the fear of like, my family not, is longer, no 
longer being there. Losing my kids, not seeing my kids anymore and just, I 
don't know just letting my parents down. (Participant 3, personal 
communication, February 18, 2021). 
 For participant 4 structural barriers actually encouraged treatment as they 
stated,  
I ended up homeless for a while and, um, I was, uh, like I said, I was 
misunderstood. I, I slept in parks, I slept, uh, in the street sometimes and 
not knowing where I was gonna go. And that’s why most of the time I had 
checked myself into one, a hospital so that they can give me hospitality 
that I needed too. I was alone. I was on the streets. (Participant 4, 
personal communication, February 9, 2021). 
Management 
Respondents reported varied methods of managing history of DD 
symptomologies from the use of prescription medicines to aid dependence, use 
of support groups, support from family, and creating changes in behavioral 
patterns such as: developing self-regulation skills; avoiding triggers; finding better 
methods of coping; and healthy dieting with exercise, even when not enrolled in 
treatment. Respondent 3 cited their efforts at keeping away, “from anybody that 
was like a trigger. Being around anybody that I knew that gets high or had 
anything to get high with, it just made that itch come right back” (Participant 3, 
personal communication, February 18, 2021). Participants reported feelings of 
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pride and accomplishment with personal development in managing DD. In 
reflecting upon this, Participant 5 stated  
It was definitely a sense of, I wanna say, almost of pride, you know, 
knowing that what once used to be a source of so much stress and 
discomfort now, now is only a small shadow of what it used to be” 
(Participant 5, personal communication, February 9, 2021). 
Perceptions towards Treatment 
When asked about their opinions to seeking DD treatment 60% of the 
participants (3 participants) reported not having considered the specific type of 
treatment. Participant 1 stated, “I never thought about that. I've never really, 
honestly, I never been like, presented with anything like that.” (Participant 1, 
personal communication, January 14, 2021). Some feelings of reluctance 
surfaced for participants who felt they could manage on their own as stated by 
Participant 3, 
It was the fact, just thinking that I was okay. You know, that, that I had 
control of the drugs, not, not the other way around… every time that I 
would get out, like I would slowly start using again, like slowly here and 
there. And I would go, ‘Well, you know, I, I got it under control. I got it 
under control.’ And then by the time that I realized I was already in jail. 
(Participant 3, personal communication, February 18, 2021).  
Upon reflection, these participants stated that if DD treatment approaches were 
available during their initial symptomologies, they might consider them as an 
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option to take. The remaining 40% (2 participants) encouraged seeking a DD 
treatment, stating they would and did seek such treatment. Participant 4 
reported, “I was the type of person that always, you know, was able to seek 
medical attention.” (Participant 4, personal communication, February 9, 2021). 
As a whole, family perceptions towards seeking treatment were good but 
there were some feelings of doubt of respondent’s ability to get treatment, 
mistrust in medication use, and fears associated with enrolling in treatment. On a 
cultural level, participants reported stigma from their community, shame from 
family members, the community’s inability to understand, and overall judgment 
against DD individuals. Participant 4 described their community as, 
They’re just very judgmental. And, um, that’s where their bottom-line lays, 
you know, I don’t think that there’s probably any people out there that give 
you that type of— or tries to even give you that type of understanding. 
(Participant 4, personal communication, February 9, 2021).  
Participant 3 reported similar accounts about their father, “he probably would 
have been ashamed” and their close peer group, “my homies, if they would have 
known they probably would have been making fun of me, you know, cracking 
jokes and stuff” (Participant 3, personal communication, February 18, 2021). 
Participant 5 noted that culturally some substances, such as alcohol, are 
normalized and even accepted whereas MHD are not. Participant 5 explained  
I think culturally substance abuse, given, depending on the substance of 
course, it doesn’t carry as much of a social stigma, even not compared to 
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mental illness. I think socially there’s more weight on mental illness than, 
you know, like in this case, alcohol consumption. So, I don’t see it being a 
topic of concern just to seek a dual diagnosis in this case. (Participant 5, 
personal communication, February 9, 2021).    
Role of Support 
Most respondents (60%) cited family support throughout substance use 
and dependency stating that parents or siblings had a major influence in always 
being present. Participant 2 emphasized the importance of this support with 
My parents were, my parents have never left my side. Never ever left my 
side. Um, and that, that, that's the reason I think I’m where I am. Where 
I'm at today because of them. Um, they didn't, they didn't, they didn't say, 
you know what, *washes-hands-off gesture* fix 'em, you know, they didn't, 
they didn't have that mindset. You know, they didn't put me in a treatment 
center and say, ‘look, we're just leaving you here. Fend for yourself.’ Um, 
they were supportive of me throughout the whole, throughout the whole 
process, um, you know, going to prison, which my addiction eventually led 
me to, um. They stayed, they remained supportive as well (Participant 2, 
personal communication, January 26, 2021). 
Participant 3 experienced the same level of support  
Even my dad as like, he was the last one to find out that I had a drug 
problem because I was scared to tell him. He didn’t find out ‘til like the last 
time that I got arrested. And I kind of just, as they were taking me in, I kind 
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of just told him like, ‘Hey man, I’m messing up, I have a drug problem. 
This and that.’ It looked like it hurt him, but I didn’t get the reaction that I 
expected from him. You know, I thought I was going to get anger and 
shame and maybe even get— maybe even lose like any support that he 
had and he was helping me with, you know, but on the contrary, you 
know, like I saw a softer side from him, you know, he kinda just stayed 
there. You know, even when I was in prison, he would, he would give me 
like good letters, you know, and just telling me, like ‘Oh, you know, hope 
you’re doing good’ tell me how he couldn’t wait for me to get out and like, 
how he was fixing a truck for me to use to start working as soon as I got 
out, like, you know, trying to get me back on my feet.” (Participant 3, 
personal communication, February 18, 2021). 
Other participants (40%) stated that family would attempt to support them but be 
unable to completely understand the circumstances.  
Summary 
This chapter has reviewed participant demographics and their 
backgrounds to contextualize the findings. Topics of interest were circumstances 
around initial substance use and MHD symptoms, personal understandings of 
DD, treatment experiences, motivations and barriers in treatment access, 
individual management skills, cultural perceptions of treatment, and supports 







This chapter will discuss the major findings from chapter 4. Following this 
will be the limitations of this study and recommendations for the social work 
profession. Recommendations are aimed at addressing social work field practice, 
policy advocacy, and academic research. The chapter closes with the 
implications of this research and a summary.  
Discussion 
Stigma 
The first major findings center on stigma from the community, where 
participants noted that friends and cultural forces would look down upon them or 
view them negatively, and how these stigmatizing perceptions made treatment 
less preferrable. Participants’ more immediate family seemed to range in support 
for treatment from skeptical to accepting. This shows that closer family ties were 
less stigmatizing than larger social forces, such as friend groups or neighbors. 
This is similar to the work of Alegria (2011) and Lo and Cheng (2011) whose 
research stated that negative perceptions of MHD and treatment led to 
disinclination to get treatment and worse outcomes. Participant 3 cited their 
peers as a source of stigma from ridicule that made them not want to get 
treatment even though their partner had recommended they seek and get 
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treatment. Participant 4 cited the community’s judgment as a disincentive but 
was still able to seek treatment. For participant 4, the community made an impact 
but this community was socially more distant than participant 3’s closer peer 
group; meaning that the proximity that the social force occupies to the individual 
may make a larger difference on the overall effects of stigma.  
Lo and Cheng (2011) discussed how these negative perceptions 
combined with insufficient care ultimately led individuals to face greater 
challenges and higher rates of morbidity. One participant’s experiences of not 
having access to treatment and their continued cycle of substance use in this 
study showed the ongoing consequences of non-treatment. This situation is 
further explained by the stigma this participant’s peer group cast upon him and 
the course of action available to him within these circumstances. Another study 
finding that not having insurance and concerns over the cost, as well as mistrust 
in psychiatric treatment were considered as major factors in never accessing 
treatment was also consistent with Lo and Cheng’s (2011) study findings. 
Self-medication 
The next theme of focus was the role of self-medication through 
substance use. This study found that all participants utilized substances to quell 
unpleasant MHD symptoms. Participants in the study reported using substances 
to ease their unpleasant symptoms and better manage their social environments 
through altered states of consciousness. This finding was supported by Owens’ 
study (2014) that found individuals with PSTD used substances as a method of 
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counteracting their PTSD symptoms. Similarly, Following the trend of Owens 
(2014), participant psycho-social functioning was also interrupted. This disruption 
was evident within the lack of scholastic engagement. Additionally, two 
schizophrenia spectrum participants faced psycho-social impairments in the form 
of homelessness and isolating behaviors. 
This study found that some participants cited the need to develop a sense 
of self-understanding and recognizing triggers for substance seeking behaviors. 
These actions fall in line with CBT techniques of re-conceptualizing ideas and 
developing alternative behaviors that benefit individual’s dysphoric symptoms. 
This finding is significant in showing that individuals who have not had access to 
treatment may still be able to do the type of self-work necessary to improve their 
conditions. Wolitzky-Taylor et al.’s (2018) study explored the capacity for 
individuals to reduce their alcohol dependence through the use of cognitive 
behavioral therapy (CBT). This intervention trend was seen even with two 
participants who did not receive treatment but still managed to initiate the 
behavioral changes needed to address their substance dependence.  
Identification and Prevention 
The following major theme is identification of a DD and how this plays a 
role in prevention of ultimately becoming Dually Diagnosed. This study found that 
the majority of the participants (60%) that received treatment within clinical 
settings were given appropriate diagnoses that guided their treatments. Those 
individuals’ treatment plans were ongoing and well maintained. Though histories 
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were varied, and different clinical settings were utilized across time, participants 
were able to benefit from clear diagnoses that dictated the proper course of 
treatment. Minkoff’s (2019) study discussed the importance of clients being 
properly diagnosed in clinical settings in order to get appropriate care that 
specifically stops cyclic patterns of dysregulation from SUD/DD. These 
participants’ success coincides with Minkoff’s (2019) assertion that, although 
sometimes complicated, proper diagnosing of applicable MHD and SUD is 
crucial. On the contrary, participants that did not engage in treatment were 
unaware of their DD status. This meant that these participants saw their MHD as 
separate from their SUD. This led to an inability to consider how one diagnosis 
may impact the other and ultimately stall any actions to address a DD.  
Similarly to Mericle et al. (2012), most participants in the study noted 
experiencing MHD before SUD. In these instances, participants reported the 
initiation of substances shortly after experiencing MHD or as a method of coping 
with their MHD. This is indicative of an important point for individuals to begin 
treatment in order to reduce DD severity in the future. Mericle et al. (2012) went 
on to state that due to this prevalence of DD, individuals face psycho-social 
barriers to employment, housing and the like. Participants within this study 
reported an income but did not specify what type of income it was. The 
participants’ psycho-social barriers were centered on community settings, 




The next theme of focus is the structural intersections to treatment. A half 
of the participants in this study discussed the way that some structural factors 
such as being uninsured, being incarcerated, having transportation difficulties, 
and having job scheduling difficulties contributed to their inability to seek 
treatment. This finding is consistent with Brown et al.’s study findings (2011) that 
discussed the structural implications, such as legal obligations, job schedule 
constraints, transportation, poor self-care, and poor self-management further 
complicated access to treatment for DDs. Addressing these types of structural 
barriers is an important step in managing a DD and lessening severity of DD 
symptoms. These structural factors further complicate individual participation in 
treatment, being that seeking treatment may already be a difficult task to initiate 
for individuals facing stigma or mistrust. In contrast to this, one participant who 
faced homelessness was able to go against the trend and reached out to 
services through hospital urgent cares and similar programs in efforts to find 
shelter in addition to treatment. This may be an incentive for some of the 
population to seek treatment.  
Wu and Hser (2011) indicated that substance treatment centers only had 
about 50% of staff certified to treat substance use and of about 25% of staff 
having a master’s degree or higher to address substance treatment needs. The 
participants who were involved in treatment in this study discussed the use of 
treatment teams having a medical doctor, therapist, and psychiatrist (if applicable 
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to individual needs) or utilizing outpatient services with an established therapist. 
Although this is a small sample of participants, the quality of services seemed 
adequate for treatment. This is a great benefit in terms of structural resources 
available to the participants. Improvements such as these are essential to 
provide better standards of care to individuals, especially those with concurrent 
diagnoses.  
Support as Empowerment 
 Finally, the socio-cultural approach that Alegria et al. (2011) proposes is 
essential to this research study in order to understand the ways that individuals 
interface with treatment and their societies. For this study, the model has been 
applied in order to focus on the individual, their capabilities, and how those 
capabilities intersect within their community’s social forces, with some context 
from the upper levels such as provider factors and federal/state policies and 
regulations. This is done in order to emphasize the power that individuals hold 
within their immediate settings and how these can transcend into larger 
mechanisms, through social workers’ mobilization. By harnessing natural 
supports in a method that reintegrates individuals into their communities and with 
their families, individuals will be able to take initial steps in creating lasting 
change. This is seen in the way that participants utilized their familial supports as 
motivations and catalysts for treatment and personal development to ultimately 




Limitations to this study are the small sample size of 5 participants who 
were all Latinx. No participants were identified as Black/ African American. Due 
to this the results of this study may not be applicable to the larger population. 
This study was conducted during the emergence of COVID-19, which further 
complicated research advertisement and participation, as all protocols were 
adapted to non-face to face communications such as Zoom or telephone calls. 
Another limitation may have been privacy and confidentiality concerns given the 
sensitivity and stigma surrounding the topic. Additionally, individuals may not 
have been aware of having a dual diagnosis, thereby thinking they would not be 
applicable for participation. Another consideration is that the qualifications for 
meeting a dual diagnosis may be too broad due to the researcher’s inability to 
formally diagnose individuals as a Master of Social Work student.  
Recommendations for Practice, Policy, and Research 
Given that most individuals in this study had MHD symptoms before 
initialing substance use and they stated the MHD as the reason or a link to 
beginning to use substances, it is highly recommended that micro-leveled social 
workers proactively assess for substance use for adolescents. This means that 
micro-leveled social workers must understand the intricacies of concurrent MHD 
and SUD, even before such dual diagnoses become apparent. Mimicking the 
way that risk assessments are preformed may be a good initial response to start 
assessing for substance use, with a special emphasis on concurrent MHDs. 
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Educating and/or providing social workers and social work students trainings on 
the intricacies of concurrent diagnoses would also be an important step for early 
detection and prevention of DD. This focus can be applied within university 
settings as an educational requirement that designates a set period of time to 
study. Social workers can also seek to develop new specialized treatment 
interventions for DD.  
Within community settings, social workers can work to eliminate the 
stigma on MHDs while simultaneously increasing awareness on the prevalence 
of SUDs. By stressing the complexity of a DD, social workers can educate the 
general population on how MHDs and SUDs can co-occur and what this DD 
means for quality of life. Once the general population is more aware of DDs, 
individuals may feel more comfortable in seeking treatment. 
On a policy (macro) level, social workers should seek to expand access to 
medical coverage for all individuals as a human right. These efforts would 
complement micro leveled approaches previously stated as more advanced 
preventative interventions. If all individuals have the options for treatment through 
medical insurance coverage presented to them to access treatment, some of the 
structural barriers that participants discussed would be alleviated. This would 
also enhance the overall wellbeing and health of individuals, which strongly 
impact mental well-being.  
Overall further research should be conducted with larger samples to get a 
better understanding of areas of improvement for treatment access. This 
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research would also aid in enabling social workers to better understand what it 
means to work with and treat dual diagnoses properly. Research could also help 
to guide the creation of a new intervention approach. A specific area of focus for 
the research to expand upon would be the specific policies that have shaped the 
health care system in respect to accessing specialized treatments. Findings here 
could provide insights for politicians and macro leveled social workers to create 
beneficial legislation for individuals with dual diagnoses.   
Conclusion 
This chapter covered the role of stigma in treatment, the role of self-
medication and how that may hinder individuals’ wellbeing, the importance of 
identification and prevention of DD, structural implications for treatment access, 
and the role of social supports. Limitations were discussed and 
























Raza / Etnicidad: 
 
2) Gender identity:  
Identidad de género:  
 
3) Age/ Edad:  ___ 18-25;  ___ 26-33;  ___ 34-41;  ___ 42-49;  ___ 50+ 
 
4) Educational level:  
Nivel educacional: 
 
5) Geographical area:  
Zona geográfica 
 
6) Medical insurance:  
Seguro médico 
 
7) Annual income range:  
Ingresos anuales: 
 
8) Diagnosis of substance disorder and mental health disorder:  
Diagnóstico de trastorno por sustancias y trastorno de salud mental: 
 














1) What was your first instance of a SUD/MHD? Around what age did it start? 
What life events were happening during that time?: 
¿Cuál fue su primera instancia de un SUD / MHD? ¿Alrededor de qué edad 
empezó? ¿Qué eventos de la vida sucedieron durante ese tiempo ?: 
 
2) Have you ever thought about a connection between SUD and MH? Have 
you ever thought they might be related? 
¿Ha pensado alguna vez en una conexión entre SUD y MH? ¿Alguna vez 
pensaste que podrían estar relacionados? 
 
3) What would you think/feel about seeking treatment for Dual Diagnosis (of 
substance use disorder/mental health disorders)? 
¿Qué pensaría / sentiría acerca de buscar tratamiento para el diagnóstico 
dual (de trastorno por uso de sustancias / trastornos de salud mental)? 
 
4) Have you ever received treatment before? What was your experience like? 
¿Ha recibido tratamiento antes? ¿Cómo fue tu experiencia? 
 
5) What things would stop you from looking for treatment? What would make 
you want to look for treatment? 
¿Qué cosas le impedirían buscar tratamiento? ¿Qué te haría querer buscar 
tratamiento? 
 
6) How have you managed or gone about dealing with DD so far? How has 
that felt? What kind of emotions or body sensations have you felt 
specifically?  
¿Cómo ha manejado o ha hecho frente al diagnóstico dual hasta ahora? 
¿Cómo se ha sentido eso? ¿Qué tipo de emociones o sensaciones 
corporales has sentido específicamente? 
 
 
7) What are your family’s feelings or thoughts towards seeking treatment? 
¿Cuáles son los sentimientos o pensamientos de su familia hacia la 





8) What would your culture or community think if you sought out treatment for 
dual diagnoses? 
¿Qué pensaría su cultura o comunidad si buscara tratamiento para el 
diagnóstico dual? 
 
9) Has your family supported or helping you manage a dual diagnosis? 
¿Su familia lo ha apoyado o ayudado a manejar un diagnóstico dual? 
 














The study that you are invited to participate in is designed to explore factors that affect 
participation in seeking and accessing treatment for dual diagnosed substance use 
disorders (SUDs) and mental health disorders (MHDs) of the Black and Latino 
populations within the Inland Empire of Southern California. This study is being 
conducted by Pedro Bañuelos, a graduate student, under the supervision of Dr. Janet 
Chang, Professor in the School of Social Work at California State University, San 
Bernardino (CSUSB). This study has been approved by the Institutional Review Board at 
CSUSB.  
 
PURPOSE: The purpose of this study is to understand the seeking and access of 
treatment for dual diagnosed SUDs and MHDs among Black and Latino populations. 
 
DESCRIPTION: Participants will be interviewed on their experiences in seeking and 
accessing treatment, thoughts on treatment approaches, barriers to treatments, supports 
for treatment, thoughts on ways to make treatment sound like better alternative. 
 
PARTICIPATION: Your participation in this study is completely voluntary and you may 
refuse or discontinue your participation at any time without any consequences.  
 
CONFIDENTIALITY: Your responses will be confidential, and data will be reported by 
population observations.  
 
DURATION: The interview will be 45 minutes to 1 hour in length.  
 
RISKS: No risks are anticipated but certain individuals may feel complex emotions from 
talking about such personal topics and experiences. Participants do not have to answer 
if they do not wish to, may skip a question or end their participation at any time.  
 
BENEFITS: No direct benefits are expected for participants. Participants may be able to 
reflect on their medical care and gain an understanding of barriers. Study findings will 
help to develop a better understanding of this area of research.  
 
CONTACT: If you have any questions about this study, please feel free to contact Dr. 
Janet Chang at (909) 537-5184. 
 
RESULTS: Results of the study can be obtained from the Pfau Library ScholarWorks 
database 




I agree to have this interview be audio recorded: _____ YES _____ NO 
 
I understand that I must be 18 years of age or older to participate in your study, have 
read and understand the 
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consent document and agree to participate in your study. 
 
 
________________________________          _____________________ 






El estudio en el que está invitado a participar está diseñado para explorar los factores 
que afectan la participación en la búsqueda y el acceso al tratamiento para los 
trastornos por uso de sustancias (TUS) y los trastornos de salud mental (MHD) de 
diagnóstico dual de las poblaciones negras y latinas dentro del Inland Empire of 
Southern California. Este estudio está siendo realizado por Pedro Bañuelos, un 
estudiante de posgrado, bajo la supervisión de la Dra. Janet Chang, Profesora de la 
Escuela de Trabajo Social de la Universidad Estatal de California, San Bernardino 
(CSUSB). Este estudio ha sido aprobado por la Junta de Revisión Institucional de CSUSB.  
 
Propósito: El propósito de este estudio es comprender la búsqueda y el acceso al 
tratamiento para los TUS y MHD de diagnóstico dual entre las poblaciones negras y 
latinas. 
 
Descripción: Se entrevistará a los participantes sobre sus experiencias en la búsqueda 
y acceso al tratamiento, pensamientos sobre enfoques de tratamiento, barreras a los 
tratamientos, apoyos para el tratamiento, y pensamientos sobre formas de hacer que el 
tratamiento parezca una mejor alternativa. 
 
Participación: Su participación en este estudio es completamente voluntaria y puede 
rechazar o interrumpir su participación en cualquier momento sin consecuencias.  
 
Confidencialidad: Sus respuestas serán confidenciales y los datos del estudio se 
informarán mediante observaciones de la población. 
 
Duración: La entrevista tendrá una duración de 45 minutos a 1 hora.  
 
Riesgos: No se anticipan riesgos, pero ciertas personas pueden sentir emociones 
complejas al hablar sobre temas y experiencias tan personales. Los participantes no 
tienen que responder si no lo desean, pueden saltarse una pregunta o finalizar su 
participación en cualquier momento.  
 
Beneficios: No se esperan beneficios directos para los participantes. Los participantes 
pueden reflexionar sobre su atención médica y comprender las barreras. Los resultados 
del estudio ayudarán a desarrollar una mejor comprensión de esta área de 
investigación. 
 
Contacto: Si tiene alguna pregunta sobre este estudio, comuníquese con la Dra. Janet 
Chang al (909)537-5184. 
 
Resultados: Los resultados del estudio se pueden obtener de la base de datos 
ScholarWorks de la biblioteca de Pfau. (http://scholarworks.lib.csusb.edu/) en la 
Universidad Estatal de California, San Bernardino después de julio de 2021. 
**************************************************************************************************** 





Entiendo que debo tener 18 años o más para participar en su estudio, haber leído y 
comprendido el 
documento de consentimiento y acepta participar en su estudio. 
 
____________________________________        _____________________ 




































This study you have just completed was designed to learn more about accessing care for 
dual diagnosed individuals. By participating you may have discussed difficult topics to 
process, so the researcher would like to offer local services that may be useful. Please 
reach out to these if needed: 
 
Este estudio que acaba de completar fue diseñado para obtener más información sobre el 
acceso a la atención para personas con diagnóstico dual. Al participar, es posible que 
haya hablado sobre temas difíciles de procesar, por lo que al investigador le gustaría 
ofrecer servicios locales que pueden ser útiles. Comuníquese con estos si es necesario: 
 
San Bernardino County/ Condado de San Bernardino 
Crisis Stabilization/ Estabilización de crisis  
• Windsor Center 
Crisis Stabilization Unit – A, ADS, C, F, MH, P 
(view legend) 
1481 N. Windsor Drive 
San Bernardino, CA 
Ph: (909) 361-6470 or 7-1-1 for TTY Users 
Hours of Operation: 24 hours a day, 7 days a week/ Horas de operación: 24 horas 
al día, 7 días a la semana 
 
• Merrill Center 
Crisis Stabilization Unit – A, ADS, C, F, MH, P 
(view legend) 
14677 Merrill Ave 
Fontana, CA 
Ph: (951) 643-2340 or 7-1-1 for TTY Users 
Hours of Operation: 24 hours a day, 7 days a week/ Horas de operación: 24 horas 
al día, 7 días a la semana 
 
Recovery Based Engagement Support Team (RBEST) provides community outreach, 
engagement, case management, family education, support, and therapy  
 (909) 421-9452 
El equipo de apoyo a la participación basada en la recuperación (RBEST) 
proporciona alcance comunitario, participación, gestión de casos, educación familiar, 




Servicios de desintoxicación 
 
• Cedar House Life Change Center 
18612 Santa Ana Ave. 
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Bloomington, CA 92316 
Phone: (909) 421-7120 
 
• Inland Valley Recovery Services 
Upland Recovery Center 
1260 Arrow Highway 
Bldg. C 
Upland, CA 91786 
Phone: (909) 932-1069 
Recovery centers – classes and sober living support 
Centros de recuperación: clases y apoyo para una vida sobria 
• Inland Valley Recovery Services 
San Bernardino Recovery Center 
939 North D Street 
San Bernardino, CA 92410 
Phone: (909) 889-6519 
 
• Inland Valley Recovery Services 
Upland Recovery Center 
934 N. Mountain Ave. 
Suites A & B 
Upland, CA 91786 
Phone: (909) 949-4667 
 
• MHS Central Valley Regional Recovery Center 
1076 Santo Antonio Drive 
Suite B 
Colton, CA 92324 
Phone: (909) 433-9824 
 
• St. John of God 
Hospitality Center 
15534 6th Street 
Victorville, CA 92393 
Phone: (760) 952-9192 
Riverside County/ Condado de Riverside 
Crisis Stabilization/ Estabilización de crisis  
• 9990 County Farm Road, Ste. 4 
Riverside, CA 92503 
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Phone: (951) 358-4881 
Se Habla Español  
 
• 85 Ramona Expressway, Suites 1-3 
Perris, CA 92571 
951-349-4195 Main 
 
• Blaine Street Adult Clinic 
769 Blaine Street, Suite B Riverside, CA 92507 
Phone: (951) 358-4705 
Fax: (951) 358-4719 
 
• Hemet Mental Health Clinic 
650 North State Street 
Hemet, CA 92543 
Phone: (951) 791-3300 
 
Substance Use Community Access, Referral, Evaluation, and Support (SU CARES) 
Line: (800) 499-3008 
 
Línea de acceso, derivación, evaluación y apoyo de la comunidad para el uso de 
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